Buy
Average AnalystN/A
Top AnalystSlightly Bearish
Stock Target AdvisorStrong Buy
Average UserUSD 33.96
+0.26 (+0.77)%
N/A
4.17M
USD 46.50(+36.93%)
Symbol | Name | Exchange | GSK's Weight | Expense Ratio | Price(Change) | Market Cap |
---|---|---|---|---|---|---|
|
HSBC UK Sustainable Equit.. | LSE | 8.36 % | 0.00 % | +0.21 (+1.16%) | USD0.01B |
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.
This stock has shown top quartile dividend growth in the previous 5 years compared to its sector
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
This stock has shown below median revenue growth in the previous 5 years compared to its sector